Literature DB >> 8858525

Epidemiology and etiology of intracranial meningiomas: a review.

M Bondy1, B L Ligon.   

Abstract

The frequency of meningiomas has been the topic of relatively few reports. Hospital-based brain tumor series indicate that the incidence is approximately 20% of all intracranial tumors; population-based studies indicate an overall incidence of 2.3/100,000. Although intracranial tumors as a whole show a higher prevalence in males than in females, meningiomas have a 2:1 female-to-male ratio. Between Caucasians and Africans, African-Americans, and Asians, certain differences also have been noted. Meningiomas in children are rare and differ from those in adults and other childhood tumors; they are even more rare in infants. Several features indicating etiologic factors have been identified, among which are ionizing radiation, head injury, hormones, and other receptor binding sites, genetic factors, and viruses. The most common source of exposure of the head to ionizing radiation is dental radiographic examination. Since 1922, head trauma has been considered a possible risk factor, but recent large studies do not support this link. Several factors have prompted studies of estrogens and progestogens as risk factors for meningiomas. Other studies have sought to determine if certain individuals have an inherited predisposition for developing a meningioma and/or if viruses, which may act alone or with other mutagens, figure into the formation of a meningioma. The most promising studies are those of cytogenetics, and future elucidation of factors associated with the loss of one copy of chromosome 22, another phenomenon that has been identified in meningiomas, may lead to screening tests and gene therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8858525     DOI: 10.1007/bf00165649

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  66 in total

1.  Meningiomas in a mother and daughter. Cases without evidence of neurofibromatosis.

Authors:  R J JOYNT; G E PERRET
Journal:  Neurology       Date:  1961-02       Impact factor: 9.910

2.  Absorbed bone marrow dose in certain dental radiographic techniques.

Authors:  S C White; T C Rose
Journal:  J Am Dent Assoc       Date:  1979-04       Impact factor: 3.634

3.  Infantile meningioma.

Authors:  M C Molleston; C J Moran; K A Roth; K M Rich
Journal:  Pediatr Neurosurg       Date:  1994       Impact factor: 1.162

Review 4.  Genetics, prognosis and therapy of central nervous system tumors.

Authors:  D Watkins; G A Rouleau
Journal:  Cancer Detect Prev       Date:  1994

5.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

6.  Neoplasms of the central nervous system in Norway. IV. A population-based epidemiological study of meningiomas.

Authors:  A Helseth; S J Mørk; A Johansen; S Tretli
Journal:  APMIS       Date:  1989-07       Impact factor: 3.205

7.  Progesterone receptor expression in meningiomas.

Authors:  R S Carroll; D Glowacka; K Dashner; P M Black
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

8.  Multiple and familial meningiomas without evidence of neurofibromatosis.

Authors:  M Y Memon
Journal:  Neurosurgery       Date:  1980-09       Impact factor: 4.654

9.  Papovavirus-related RNA sequences in human neurogenic tumours.

Authors:  H Ibelgaufts; K W Jones
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

10.  Meta-analysis of progestin and estrogen receptors in human meningiomas.

Authors:  S Gabos; J Berkel
Journal:  Neuroepidemiology       Date:  1992       Impact factor: 3.282

View more
  95 in total

Review 1.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

2.  Exploring new frontiers in molecular imaging: Emergence of Ga PET/CT.

Authors:  Eik Hock Tan; Soon Whatt Goh
Journal:  World J Radiol       Date:  2010-02-28

Review 3.  Stereotactic radiosurgery for benign meningiomas.

Authors:  Orin Bloch; Gurvinder Kaur; Brian J Jian; Andrew T Parsa; Igor J Barani
Journal:  J Neurooncol       Date:  2011-10-18       Impact factor: 4.130

4.  Demographic profile of patients diagnosed with intracranial meningiomas in two academic hospitals in Johannesburg, South Africa: a 12-month prospective study.

Authors:  Kaunda Ibebuike; John Ouma
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

5.  Dural-based lesions: is it a meningioma?

Authors:  Vitor Nagai Yamaki; Luis Filipe de Souza Godoy; Gabriela Alencar Bandeira; Leandro Tavares Lucato; Gustavo Correa Lordelo; Davi Jorge Fontoura Solla; Iuri Santana Neville; Manoel Jacobsen Teixeira; Wellingson Silva Paiva
Journal:  Neuroradiology       Date:  2021-01-18       Impact factor: 2.804

6.  The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases.

Authors:  Ruo-Fei Liang; Ying-Jie Xiu; Xiang Wang; Mao Li; Yuan Yang; Qing Mao; Yan-Hui Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

7.  Salvage chemotherapy with CPT-11 for recurrent meningioma.

Authors:  Marc C Chamberlain; Denice D Tsao-Wei; Susan Groshen
Journal:  J Neurooncol       Date:  2006-04-21       Impact factor: 4.130

Review 8.  Contemporary endovascular embolotherapy for meningioma.

Authors:  Gregory J Dubel; Sun Ho Ahn; Gregory M Soares
Journal:  Semin Intervent Radiol       Date:  2013-09       Impact factor: 1.513

9.  Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.

Authors:  Beatrice Detti; Silvia Scoccianti; Vanessa Di Cataldo; Eleonora Monteleone; Samantha Cipressi; Lorenzo Bordi; Gianni Pellicanò; Davide Gadda; Calogero Saieva; Daniela Greto; Guido Pecchioli; Annamaria Buccoliero; Marco Ceroti; Franco Ammannati; Giampaolo Biti
Journal:  J Neurooncol       Date:  2013-09-18       Impact factor: 4.130

10.  Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

Authors:  Patrick Y Wen; W K Alfred Yung; Kathleen R Lamborn; Andrew D Norden; Timothy F Cloughesy; Lauren E Abrey; Howard A Fine; Susan M Chang; H Ian Robins; Karen Fink; Lisa M Deangelis; Minesh Mehta; Emmanuelle Di Tomaso; Jan Drappatz; Santosh Kesari; Keith L Ligon; Ken Aldape; Rakesh K Jain; Charles D Stiles; Merrill J Egorin; Michael D Prados
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.